Guoqiang Yang
Shanxi Provincial Key Laboratory Of Major Diseases Risk Assessment
Taiyuan, 030001, China
Taiyuan, 030001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Neoadjuvant Toripalimab Plus Axitinib for Nonmetastatic Clear Cell Renal Cell Carcinoma With Tumor Thrombus: A Combined Analysis of Two Phase II Clinical Trials.
Journal: MedComm
Published: October 28, 2025
Development and validation of radiopathomics models for predicting molecular subtypes and WHO grades in adult-type diffuse gliomas: a multicenter study.
Journal: Journal of translational medicine
Published: June 08, 2025
Survival risk stratification of 2021 WHO glioblastoma by MRI radiomics and biological exploration.
Journal: BMC cancer
Published: June 04, 2025
Development and validation of a CT-based radiomics nomogram for predicting cervical lymph node metastasis in papillary thyroid carcinoma.
Journal: Cancer biomarkers : section A of Disease markers
Published: April 28, 2025
MRI transformer deep learning and radiomics for predicting IDH wild type TERT promoter mutant gliomas.
Journal: NPJ precision oncology
Published: December 01, 2024
MRI-based habitat imaging predicts high-risk molecular subtypes and early risk assessment of lower-grade gliomas.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: May 08, 2024
Diffusion kurtosis imaging-based habitat analysis identifies high-risk molecular subtypes and heterogeneity matching in diffuse gliomas.
Journal: Annals of clinical and translational neurology
Published: March 06, 2024
Last Updated: 09/26/2026